Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Further Evidence for Strong Nonneutrality of Yeast Synonymous Mutations.
Journal: Molecular biology and evolution
Published: July 21, 2024
Interpretable machine learning leverages proteomics to improve cardiovascular disease risk prediction and biomarker identification.
Journal: Communications medicine
Published: March 28, 2024
Chance promoter activities illuminate the origins of eukaryotic intergenic transcriptions.
Journal: Nature communications
Published: August 04, 2022
A multiplexed in vivo approach to identify driver genes in small cell lung cancer.
Journal: Cell reports
Published: March 24, 2022
Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment.
Journal: Molecular & cellular oncology
Published: March 07, 2022
Synonymous mutations in representative yeast genes are mostly strongly non-neutral.
Journal: Nature
Published: August 03, 2021
Quantitative In Vivo Analyses Reveal a Complex Pharmacogenomic Landscape in Lung Adenocarcinoma.
Journal: Cancer research
Published: March 04, 2021
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo.
Journal: Cancer discovery
Published: September 25, 2020
A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS-Driven Lung Cancer.
Journal: Cancer discovery
Published: September 14, 2020
The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D.
Journal: Nature
Published: March 06, 2020
Stop-codon read-through arises largely from molecular errors and is generally nonadaptive.
Journal: PLoS genetics
Published: February 18, 2019
Last Updated: 09/26/2026